- Home
- TRSG vs CLNN Comparison
TRSG vs CLNN Comparison
Compare TRSG & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- CLNN
- Stock Information
- Founded
- TRSG 1996
- CLNN 2012
- Country
- TRSG Singapore
- CLNN United States
- Employees
- TRSG N/A
- CLNN N/A
- Industry
- TRSG
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- CLNN Health Care
- Exchange
- TRSG NYSE
- CLNN Nasdaq
- Market Cap
- TRSG 25.8M
- CLNN 26.1M
- IPO Year
- TRSG 2024
- CLNN N/A
- Fundamental
- Price
- TRSG $1.51
- CLNN $2.83
- Analyst Decision
- TRSG
- CLNN Strong Buy
- Analyst Count
- TRSG 0
- CLNN 5
- Target Price
- TRSG N/A
- CLNN $50.20
- AVG Volume (30 Days)
- TRSG 46.6K
- CLNN 51.0K
- Earning Date
- TRSG 12-31-2024
- CLNN 05-07-2025
- Dividend Yield
- TRSG N/A
- CLNN N/A
- EPS Growth
- TRSG N/A
- CLNN N/A
- EPS
- TRSG N/A
- CLNN N/A
- Revenue
- TRSG $14,441,864.00
- CLNN $342,000.00
- Revenue This Year
- TRSG N/A
- CLNN N/A
- Revenue Next Year
- TRSG N/A
- CLNN $2,066.67
- P/E Ratio
- TRSG N/A
- CLNN N/A
- Revenue Growth
- TRSG 9.34
- CLNN N/A
- 52 Week Low
- TRSG $1.00
- CLNN $2.57
- 52 Week High
- TRSG $11.78
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- CLNN 34.63
- Support Level
- TRSG N/A
- CLNN $2.76
- Resistance Level
- TRSG N/A
- CLNN $3.18
- Average True Range (ATR)
- TRSG 0.00
- CLNN 0.25
- MACD
- TRSG 0.00
- CLNN 0.05
- Stochastic Oscillator
- TRSG 0.00
- CLNN 38.33
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.